Pain in the BaaS.

Google in biotech.

Post-mortem insights.

 

View in browser

CB-Insights-Logo-light copy

June 20, 2024

Revved up

Hi there, 

 

Here is this week's Hot or Not.

 

Hot: OpenAI revenue

 

OpenAI is on track for $3.4B in annual revenue per The Information, doubling its annualized revenue figure from late 2023. 

 

Around $200M of that is from Microsoft’s re-selling of OpenAI models on Azure. 

 

Anthropic, which reported $100M in annualized revenue in September 2023, projected it will generate $850M in annualized revenue by the end of 2024.

openai revenue june 2024 v2

It’s unclear how much of OpenAI’s and Anthropic’s revenues are due to individual subscriptions vs. enterprise deals, but both are doubling down on the enterprise segment. 

  • Anthropic announced its enterprise Claude Team plan in May. 
  • OpenAI also announced fresh exec hires last week as it focuses on growth: former Nextdoor CEO Sarah Friar is joining as Chief Financial Officer and Kevin Weil, with product experience at Facebook and Twitter, as Chief Product Officer.

Cohere, which had $35M in annualized revenue at the end of Q1, has not built a consumer chatbot and is focused on the enterprise market.

 

While enterprise customers are increasingly promiscuous using models from multiple developers (as we explored on Tuesday here), OpenAI continues to lead in terms of adoption based on CBI software buyer interviews.

 

Not: Banking-as-a-service (BaaS) headcounts

 

BaaS startup Unit let go 15% of its staff this week. The company joins others in the market like Treasury Prime and Synctera that restructured this year. 

 

BaaS providers use application programming interfaces (APIs) to enable banks, fintechs, and companies outside of financial services to offer banking and payment products to end users. 

 

Regulatory scrutiny on bank and fintech partnerships has put pressure on the market, and it’s recently seen a wave of consolidation and shutdowns. For example, Synapse filed for bankruptcy in April 2024. 


We map the market here and cover consolidation here. 

baas headcount june 2024

Hot: Google in biotech

 

Big tech players are going after healthcare — and each co is carving out a distinct strategy.

 

For example, Google is sharpening its biotech focus.

 

Biotech has accounted for a quarter of Google Ventures’ investments in 2024 so far (as of May 30).

 

Two of its most recent bets went to companies focused on developing cancer drugs: Delphia Therapeutics and BridgeBio Oncology Therapeutics.

 

Where else is Google doubling down — and how does its strategy compare to those of its big tech peers?


Find out in our big tech in healthcare report.

google biotech june 2024

Not: Unsuccessful pivots

 

We recently highlighted that the latest wave of startup deaths included many autonomous driving companies.

 

But we didn’t dig too deep into exactly what happened to these startups, so let’s take a closer look.

 

CBI customers can generate insights into a dead co’s funding history to learn more about its rise and fall.


For Ghost Autonomy, funding insights reveal that the company attempted to pivot multiple times in the lead-up to its shutdown.

ghost autonomy_funding insights_overview

Customers can then drill down on its “dead” round to identify the specific strategic moves that ultimately fell flat.

 

In Ghost’s case, the startup flipped from highway autonomy to crash prevention tech to leveraging LLMs for self-driving — even drawing funding from the OpenAI Startup Fund — but to no avail.

ghost autonomy_funding insights_dead round

Explore post-mortem insights on Ghost Autonomy and 9 other failed startups in our latest update on startup death.

 

The +1

trippy x axis plus one

Far out. This is one trippy x-axis. Big thanks to NL reader Scott Solak for sharing this fugly chart.

 

I love you.

 

Anand 

@asanwal 


P.S. Our analysts recently dove into the trends you should be watching in the second half of 2024. Learn more about what’s on their radar in the briefing recording.

Get started with CB Insights

Start your free trial

CB Insights' emerging technology insights platform provides all the

analysis and data from this newsletter. Our data is the easiest way to discover and respond to emerging tech. 

Was this email forwarded to you? Sign up here

X
LinkedIn
CB-Insights-Icon-Light

Copyright © 2024 CB Insights, All rights reserved.

498 7th Avenue, NY, CB Insights, New York,10018

About Us | Update Preferences | Research | Newsletter